Pseudohypoaldosteronism type 2E

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:300530OMIM:614496I15.1
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Pseudohypoaldosteronism type 2E (PHA2E) is a rare genetic condition that causes high blood pressure (hypertension) along with high potassium levels in the blood (hyperkalemia). It is also known as Gordon syndrome type E or familial hyperkalemic hypertension type 2E. This condition is part of a group of disorders collectively called pseudohypoaldosteronism type 2 (PHA2) or Gordon syndrome. In PHA2E, the body's kidneys have trouble properly balancing salt (sodium) and potassium. Normally, the kidneys filter out excess potassium and reabsorb the right amount of sodium. In this disease, the kidneys hold on to too much sodium and potassium, which leads to high blood pressure and dangerously high potassium levels. The condition is caused by mutations in the KLHL3 gene, which plays a role in regulating kidney salt transporters. Symptoms often include high blood pressure that may begin in childhood or early adulthood, along with metabolic acidosis (too much acid in the blood). Some patients may also experience muscle weakness or fatigue related to electrolyte imbalances. The good news is that PHA2E often responds well to treatment with thiazide diuretics, a type of water pill that helps the kidneys get rid of excess sodium and potassium. With proper treatment, blood pressure and potassium levels can usually be brought under control, significantly improving quality of life.

Also known as:

Key symptoms:

High blood pressureHigh potassium levels in the bloodMetabolic acidosis (too much acid in the blood)Muscle weaknessFatigueLow renin levels in the bloodNormal or high aldosterone levelsHeadaches from high blood pressureNumbness or tingling in hands and feetHeart rhythm problems from high potassiumShort stature in some cases

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Pseudohypoaldosteronism type 2E.

View clinical trials →

No actively recruiting trials found for Pseudohypoaldosteronism type 2E at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Pseudohypoaldosteronism type 2E community →

No specialists are currently listed for Pseudohypoaldosteronism type 2E.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Pseudohypoaldosteronism type 2E.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Pseudohypoaldosteronism type 2EForum →

No community posts yet. Be the first to share your experience with Pseudohypoaldosteronism type 2E.

Start the conversation →

Latest news about Pseudohypoaldosteronism type 2E

No recent news articles for Pseudohypoaldosteronism type 2E.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What dose of thiazide diuretic is right for me or my child, and how often should it be taken?,How often do I need blood tests to check my potassium and kidney function?,Are there any medications or supplements I should avoid because they could raise potassium levels?,Should other family members be tested for this condition?,What dietary changes should I make, especially regarding salt and potassium intake?,What are the warning signs that my potassium is too high and I need emergency care?,Will I need to take medication for the rest of my life?

Common questions about Pseudohypoaldosteronism type 2E

What is Pseudohypoaldosteronism type 2E?

Pseudohypoaldosteronism type 2E (PHA2E) is a rare genetic condition that causes high blood pressure (hypertension) along with high potassium levels in the blood (hyperkalemia). It is also known as Gordon syndrome type E or familial hyperkalemic hypertension type 2E. This condition is part of a group of disorders collectively called pseudohypoaldosteronism type 2 (PHA2) or Gordon syndrome. In PHA2E, the body's kidneys have trouble properly balancing salt (sodium) and potassium. Normally, the kidneys filter out excess potassium and reabsorb the right amount of sodium. In this disease, the kidney

How is Pseudohypoaldosteronism type 2E inherited?

Pseudohypoaldosteronism type 2E follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.